​​The Health Resources and Services Administration (HRSA) is expected to propose a further delay in the effective date of a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B drug savings program, according to a notice under review at the Office of Management and Budget. HRSA has delayed the effective date of the rule many times. The most recent delay, which was announced last August, set July 1 as the effective date for the rule. It is not clear what date HRSA will propose for the new effective date. Last September, the American Hospital Association (AHA) opposed any further delay of the rule.  ​